TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients.
Status:
Unknown status
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy TONKA on the reduction of ALT and AST
in moderate to severe liver enzyme elevated patients; compared with Silymarin (Legalon) after
6 weeks of treatment.